Clinical Trials Browser

Phase 3 × Methylprednisolone Hemisuccinate × Other hematologic neoplasm × Clear all

NCT00568633 2019-09-24

Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML

Phase 3 Terminated

58 enrolled 18 charts

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT00929695 2017-08-21

Low-Dose Prednisone or Methylprednisolone in Treating Patients With Newly Diagnosed Acute Graft-versus-Host Disease

Phase 3 Completed

164 enrolled 19 charts

LymphoidOther hematologic neoplasm

Graft vs Host Disease, Precursor Cell Lymphoblastic Leukemia-Lymphoma